Physician profile
Jonathan Michael King
NPI 1174779441
$11,750.31
in general payments reported to CMS, 2019-2025
22 companies · $2,580 in 2025
The $2,580 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $139 · 2021: $404 · 2022: $3,256 · 2023: $2,819 · 2024: $2,142 · 2025: $2,580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,145 · Food and Beverage: $2,397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,145.21 |
| Food and Beverage | $2,396.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $7,181.41 | 2022-2025 | |
| Arthrex, INC. | $1,567.68 | 2022 | |
| Stryker Corporation | $1,166.04 | 2019-2025 | Augment Injectable, Citrefix, Infinity |
| Pinnacle, INC | $852.42 | 2022-2023 | |
| Amgen INC. | $219.13 | 2024-2025 | Krystexxa |
| Mimedx Group, INC. | $131.58 | 2024 | |
| Depuy Synthes Sales INC. | $120.89 | 2020-2025 | Motoband, Na |
| Horizon Therapeutics Plc | $103.86 | 2019-2023 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $61.68 | 2020-2022 | |
| Globus Medical, INC. | $53.69 | 2024 | Foot System |
| Osteomed LLC | $52.06 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $38.78 | 2024 | Nuzyra |
| Abbvie INC. | $29.99 | 2022 | |
| Orthofix Medical, INC. | $29.93 | 2020-2025 | Physio-Stim |
| Nevro Corp. | $26.90 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $26.86 | 2022 | |
| Wright Medical Technology, INC. | $18.35 | 2019 | |
| Sebela Pharmaceuticals INC. | $16.81 | 2019 | |
| Hartmann USA, INC. | $16.55 | 2024 | Zetuvit Plus 10x10 P10 |
| Paragon 28, INC. | $16.50 | 2020 | |
| Medtronic, INC. | $15.59 | 2023 | Accurian |
| Organogenesis INC. | $3.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.